US Stock MarketDetailed Quotes

ABCL AbCellera Biologics

Watchlist
  • 2.585
  • -0.335-11.47%
Close Feb 28 16:00 ET
  • 2.600
  • +0.015+0.58%
Post 19:58 ET
770.30MMarket Cap-4.70P/E (TTM)

AbCellera Biologics Key Stats

AbCellera Biologics Q4 2024 Earnings Date

Currency:USDFeb 27, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
7.58M
5.05M
-2.53M
Miss Est.
-17.62%
-44.98%
-33.37%
EPS
-0.15
-0.11
+0.04
Beat Est.
+8.57%
+35.29%
+24.76%
Strong Buy

Feb 28, 2025

AbCellera Biologics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 5.599M--
--2025/Q1-- / 5.590M--
Feb 27, 20252024/Q45.100M / 7.579M--
Nov 4, 20242024/Q36.507M / 8.015M--
Aug 6, 20242024/Q27.323M / 10.015M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 5.599M--
--2025/Q1-- / 5.590M--
Feb 27, 20252024/Q45.100M / 7.579M--
Nov 4, 20242024/Q36.507M / 8.015M--
Aug 6, 20242024/Q27.323M / 10.015M--

Unlock Free Earnings Estimates

AbCellera Biologics Earnings Reports

Read more

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
Unlock Now
Discussing
Tesla's earnings caused fluctuations, what's your market outlook?
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More